Directory | News | Giving | Maps/Directions

Health sciences Research & education Patient care
David Geffen School of Medicine at UCLA

Volunteering  |  Jobs  |  FAQs  |  Biomed Library  |  Site Map  |  Contact Us

About Us
Education
Medical Student Admissions
Research
Departments
Faculty Search
Administration
Resources for Faculty
Resources for Residents
Resources for Medical Students
Graduate Student Education
Alumni
Community Outreach
Clinical Trials
Tomas Ganz, M.D., Ph.D.
   
 
Affiliations
Professor, Medicine, ACCESS Program: Dept. of Cellular & Molecular Pathology, Pathology and Laboratory Medicine
Director, ACCESS Program: Dept. of Cellular & Molecular Pathology
Member, Experimental Pathology, JCCC Hematopoietic Malignancies Program Area

Education:
Medical Degree: M.D., UCLA
Degree: Ph.D., Applied Physics, California Institute of Technology


Contact Information:
Work Email Address: tganz@mednet.ucla.edu
Work Address: Office
CHS
Los Angeles, CA 90095
UNITED STATES
Work Address: 37-055 - CHS
Campus -169017
CA
UNITED STATES
Home Page: http://www.defense.med.ucla.edu/


Direct Contact Information:
Work Phone Number: (310) 825-6112
310-825-0133
310-825-749


Additional Information:

Dr. Tomas Ganz received his Ph.D. in Applied Physics from Caltech in 1976 and M.D. from UCLA in 1978. After training in Internal Medicine and Pulmonary Medicine at UCLA, he joined the faculty in 1983. He has a joint appointment in the Departments of Medicine and Pathology and is involved in the graduate program in Molecular and Cellular Pathology.

Publications:
Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006; 108(12): 3730-5.
Nemeth E, Preza GC, Jung CL, Kaplan J, Waring AJ, Ganz T The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 2006; 107(1): 328-33.
Ganz T Hepcidin in iron metabolism. Curr Opin Hematol. 2004; 11(4): 251-4.
Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet. 2004; 36(1): 77-82.
Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein (Plenary Article). Blood. 2003; 101: 2461-2463.
Sham Ronald L, Phatak Pradyumna D, Nemeth Elizabeta, Ganz Tomas Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation.. Blood. 2009; 114(2): 493-4.
Fernandes Augustine, Preza Gloria C, Phung Yen, De Domenico Ivana, Kaplan Jerry, Ganz Tomas, Nemeth Elizabeta The molecular basis of hepcidin-resistant hereditary hemochromatosis.. Blood. 2009; 114(2): 437-43.
Ganz Tomas, Olbina Gordana, Girelli Domenico, Nemeth Elizabeta, Westerman Mark Immunoassay for human serum hepcidin.. Blood. 2008; 112(10): 4292-7.
Ganz Tomas Iron homeostasis: fitting the puzzle pieces together.. Cell metabolism. 2008; 7(4): 288-90.
Valore Erika V, Ganz Tomas Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin.. Blood cells, molecules & diseases. 2008; 40(1): 132-8.
Lin Lan, Nemeth Elizabeta, Goodnough Julia B, Thapa Dharma R, Gabayan Victoria, Ganz Tomas Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site.. Blood cells, molecules & diseases. 2008; 40(1): 122-31.
Lin Lan, Valore Erika V, Nemeth Elizabeta, Goodnough Julia B, Gabayan Victoria, Ganz Tomas Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4.. Blood. 2007; 110(6): 2182-9.
Lin L, Goldberg YP, Ganz T Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin.. Blood. . 2005; 106(8): 2884-9.
Linzmeier RM, Ganz T Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23.. Genomics.. 2005; 86(4): 423-30.
Rivera S, Nemeth E, Gabayan V, Lopez MA, Farshidi D, Ganz T Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.. Blood. . 2005; 106(6): 2196-9.
De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, Kaplan J The molecular basis of ferroportin-linked hemochromatosis.. Proceedings of the National Academy of Sciences of the United States of America. . 2005; 102(25): 8955-60.
Rivera S, Liu L, Nemeth E, Gabayan V, Sorensen OE, Ganz T Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia.. Blood. . 2005; 105(4): 1797-802.
Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C Hepcidin is decreased in TFR2 hemochromatosis.. Blood. . 2005; 105(4): 1803-6.
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.. Science. . 2004; 306(5704): 2090-3.
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.. The Journal of clinical investigation. . 2004; 113(9): 1271-6.
Ganz T Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation.. Blood. . 2003; 102(3): 783-8.
Park CH, Valore EV, Waring AJ, Ganz T Hepcidin, a urinary antimicrobial peptide synthesized in the liver.. The Journal of biological chemistry. . 2001; 276(11): 7806-10.


UCLA Health Sciences UCLA Terms & Conditions Privacy Practices Disability Resources © UC Regents